
60 DEGREES PHARMACEUTICALS, INC. — Investor Relations & Filings
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of medicines for infectious diseases. The company's primary efforts are directed towards tropical diseases with significant unmet medical needs. Its portfolio includes a commercially available product for malaria prevention and a development program for a dengue fever treatment. The company's clinical pipeline also extends to other infectious diseases, such as babesiosis. Through collaborations with research organizations, 60 Degrees Pharmaceuticals aims to discover, develop, and distribute innovative therapies for patients worldwide.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| CURRENT REPORT | 2026-05-18 | English | |
| 10-Q | 2026-05-15 | English | |
| 8-K - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Filer) | 2026-03-20 | English | |
| 8-K Filing | 2026-02-12 | English | |
| CURRENT REPORT | 2026-01-23 | English | |
| CURRENT REPORT | 2026-01-21 | English |
Browse filings by year
5 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 46460988 | CURRENT REPORT | 2026-05-18 | English | ||
| 46353984 | 10-Q | 2026-05-15 | English | ||
| 33002179 | 8-K - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Filer) | 2026-03-20 | English | ||
| 32241028 | 8-K Filing | 2026-02-12 | English | ||
| 13618397 | CURRENT REPORT | 2026-01-23 | English | ||
| 13618398 | CURRENT REPORT | 2026-01-21 | English | ||
| 13618399 | CURRENT REPORT | 2026-01-08 | English | ||
|
2025
8 filings
| |||||
| 13618401 | Director's Dealing 2025 | 2025-12-16 | English | ||
| 13618400 | OWNERSHIP DOCUMENT | 2025-12-12 | English | ||
| 13618402 | Major Shareholding Notification 2025 | 2025-11-13 | English | ||
| 13618404 | 10-Q | 2025-11-13 | English | ||
| 13618403 | Major Shareholding Notification 2025 | 2025-11-07 | English | ||
| 13618405 | Major Shareholding Notification 2025 | 2025-11-07 | English | ||
| 13618406 | CURRENT REPORT | 2025-10-10 | English | ||
| 13618407 | Director's Dealing 2025 | 2025-09-15 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Enervit
Develops sports nutrition, functional foods, and wellness s…
|
ENV | IT | Manufacturing |
|
enGene Holdings Inc.
Clinical-stage biotech developing non-viral gene therapies …
|
ENGN | CA | Manufacturing |
|
Enliven Therapeutics, Inc.
Clinical-stage biopharma developing kinase inhibitors for p…
|
ELVN | US | Manufacturing |
|
Enlivex Therapeutics Ltd.
A clinical-stage macrophage reprogramming immunotherapy com…
|
ENLV | IL | Manufacturing |
|
Enlivex Therapeutics Ltd.
Develops macrophage reprogramming immunotherapy for inflamm…
|
ENLV | US | Manufacturing |
|
Enorama Pharma AB
Develops and manufactures medicated chewing gums and tobacc…
|
ERMA | SE | Manufacturing |
|
Ensol Biosciences Inc.
AI-driven biopharma developing peptide drugs for unmet medi…
|
140610 | KR | Manufacturing |
|
Entera Bio Ltd.
A clinical-stage company developing oral peptide and protei…
|
ENTX | IL | Manufacturing |
|
Entero Therapeutics, Inc.
Clinical-stage biopharma developing oral therapies for gast…
|
ENTO | US | Manufacturing |
|
Entourage Health Corp.
Licensed cannabis producer serving medical, recreational, a…
|
ENTG | CA | Manufacturing |
60 DEGREES PHARMACEUTICALS, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35377/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35377 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35377 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35377 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35377}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for 60 DEGREES PHARMACEUTICALS, INC. (id: 35377)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.